Skip to main content
. 2020 Nov 13;99(46):e23053. doi: 10.1097/MD.0000000000023053

Table 1.

Baseline characteristics of patients.

Total, N = 22
Age (yrs), mean (range) 47.5 (36–62)
Clinical stage
 Tumor stage, no. (%)
  T1 2 (9.1)
  T2 13 (59.1)
  T3–T4 7 (31.8)
 Nodal stage, no. (%)
  N1 15 (68.2)
  N2 4 (18.2)
  N3 3 (13.6)
 Hormone receptor status, no. (%)
  Positive 7 (31.8)
  Negative 15 (68.2)
 Histologic grade, no. (%)
  G1 0 (0)
  G2 19 (86.4)
  G3 3 (13.6)
 Ki-67, no. (%)
  <10% 3 (13.6)
  10–20% 3 (13.6)
  ≥20% 16 (72.7)
 Menopause status, no. (%)
  Pre-menopause 12 (54.5)
  Post-menopause 10 (45.5)